BCYC
Bicycle Therapeutics plc
$8.07
-$0.69(-7.88%)
56
Overall
60
Value
66
Tech
44
Quality
Market Cap
$569.70M
Volume
309.26K
52W Range
$6.10 - $25.39
Target Price
$24.90
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $13.8M | $10.4M | $11.7M | $14.5M | $27.0M | $35.3M | ||
| Total Revenue | $13.8M | $10.4M | $11.7M | $14.5M | $27.0M | $35.3M | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $13.8M | $10.4M | $11.7M | $14.5M | $27.0M | $35.3M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $40.1M | $62.4M | $77.3M | $130.6M | $216.9M | $245.1M | ||
| Research & Development | $25.5M | $33.1M | $44.9M | $81.6M | $156.5M | $173.0M | ||
| Research Expense | $25.5M | $33.1M | $44.9M | $81.6M | $156.5M | $173.0M | ||
| Selling, General & Administrative | $14.6M | $29.2M | $32.4M | $49.5M | $60.4M | $72.2M | ||
| General & Administrative Expenses | $14.6M | $29.2M | $32.4M | $49.5M | $60.4M | $72.2M | ||
| Salaries & Wages | -- | -- | -- | $26.8M | $32.5M | $38.1M | ||
| Depreciation & Amortization | $1.0M | $1.3M | $1.4M | $3.7M | $6.5M | $7.2M | ||
| Depreciation & Amortization | $1.0M | $1.3M | $1.4M | $3.7M | $6.5M | $7.2M | ||
| Amortization | -- | -- | -- | -- | -- | $100.0K | ||
| Other Operating Expenses | $40.1M | $1.6M | $1.8M | $5.4M | $216.9M | $245.1M | ||
| OPERATING INCOME | ||||||||
| Operating income | $-26.3M | $-52.0M | $-65.6M | $-116.7M | $-189.9M | $-209.9M | ||
| EBITDA | $-29.9M | $-50.0M | $-64.1M | $-110.9M | $-172.7M | $-164.9M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | -- | $457.0K | $3.0M | $3.3M | $3.3M | $1.7M | ||
| Intinc | $814.0K | $683.0K | $120.0K | $5.8M | $14.0M | $34.3M | ||
| Net Non-Operating Interest Income/Expense | $814.0K | $226.0K | $-2.9M | $2.4M | $14.0M | $34.3M | ||
| Other Income/Expense | $5.4M | $-226.0K | -- | $-555.0K | $-594.0K | $1.0M | ||
| Other Special Charges | $-5.4M | $226.0K | -- | -- | -- | $-1.0M | ||
| SPECIAL ITEMS | ||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | $2.0M | ||
| Special Income Charges | -- | $-4.7M | -- | -- | -- | $-2.0M | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-30.9M | $-51.3M | $-65.5M | $-110.9M | $-179.2M | $-172.1M | ||
| Pre-Tax Income | $-30.9M | $-51.7M | $-68.5M | $-114.2M | $-179.2M | $-173.8M | ||
| INCOME TAX | ||||||||
| Tax Provision | $-254.0K | $-700.0K | $-1.7M | $-1.5M | $1.5M | $-4.8M | ||
| NET INCOME | ||||||||
| Net Income | $-30.6M | $-51.0M | $-66.8M | $-112.7M | $-180.7M | $-169.0M | ||
| Net Income (Continuing Operations) | $-30.6M | $-51.0M | $-66.8M | $-112.7M | $-180.7M | $-169.0M | ||
| Net Income (Discontinued Operations) | $-30.6M | $-51.0M | $-66.8M | $-112.7M | $-180.7M | $-169.0M | ||
| Net Income (Common Stockholders) | $-30.6M | $-51.0M | $-66.8M | $-112.7M | $-180.7M | $-169.0M | ||
| TOTALS | ||||||||
| Total Expenses | $40.1M | $62.4M | $77.3M | $130.6M | $216.9M | $245.1M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $11.0M | $19.1M | $25.1M | $29.7M | $35.6M | $58.2M | ||
| Average Shares Outstanding (Diluted) | $11.0M | -- | $25.1M | $29.7M | $35.6M | $58.2M | ||
| Shares Outstanding | $18.0M | $23.1M | $29.6M | $30.0M | $49.9M | $69.2M | ||
| Basic EPS | $-2.77 | $-2.66 | $-2.67 | $-3.8 | $-5.08 | $-2.9 | ||
| Basic EPS (Continuing Operations) | $-2.77 | $-2.66 | $-2.67 | $-3.8 | $-5.08 | $-2.9 | ||
| Diluted EPS | $-2.77 | $-2.66 | $-2.67 | $-3.8 | $-5.08 | $-2.9 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-2.67 | $-3.8 | $-5.08 | $-2.9 | ||
| OTHER METRICS | ||||||||
| Non Recurring Operation Expense | -- | $4.7M | -- | -- | -- | -- | ||
| Other Gand A | $14.6M | $29.2M | $32.4M | $49.5M | $60.4M | $72.2M | ||
| Restruct | -- | -- | -- | -- | -- | $2.0M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCYC | $8.07 | -7.9% | 309.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bicycle Therapeutics plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW